LY6E and neoplasm: On anti-Ly6E, the modification results in reduced tumor accumulation, potentially due to reduced anti-Ly6E affinity and/or increased size reducing ADC diffusion.23 Single doses of anti-Ly6E-CBI drove targeted activity across a range of Ly6E expression levels.